相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Evolution of Multiple Sclerosis Disability in the Treatment Era
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2016)
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis
Martina Absinta et al.
NEUROLOGY (2015)
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
Dalia L. Rotstein et al.
JAMA NEUROLOGY (2015)
The Charcot Lecture vertical bar Beating MS: A story of B cells, with twists and turns
Stephen L. Hauser
MULTIPLE SCLEROSIS JOURNAL (2015)
Age, Gender and Normalization Covariates for Spinal Cord Gray Matter and Total Cross-Sectional Areas at Cervical and Thoracic Levels: A 2D Phase Sensitive Inversion Recovery Imaging Study
Nico Papinutto et al.
PLOS ONE (2015)
Spinal Cord Gray Matter Atrophy Correlates with Multiple Sclerosis Disability
Regina Schlaeger et al.
ANNALS OF NEUROLOGY (2014)
Meningeal and cortical grey matter pathology in multiple sclerosis
Bogdan F. Gh Popescu et al.
BMC NEUROLOGY (2012)
Cortical lesion load associates with progression of disability in multiple sclerosis
Massimiliano Calabrese et al.
BRAIN (2012)
B cell exchange across the blood-brain barrier in multiple sclerosis
H. -Christian von Buedingen et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis
Douglas S. Goodin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
The neuropathological basis of clinical progression in multiple sclerosis
Richard Reynolds et al.
ACTA NEUROPATHOLOGICA (2011)
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial
Ludwig Kappos et al.
LANCET (2011)
A Gradient of Neuronal Loss and Meningeal Inflammation in Multiple Sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2010)
Gray matter atrophy is related to long-term disability in multiple sclerosis
Leonora K. Fisniku et al.
ANNALS OF NEUROLOGY (2008)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2008)
B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis
Stephen L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
New natural history of interferon-β treated relapsing multiple sclerosis
Maria Trojano et al.
ANNALS OF NEUROLOGY (2007)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Risk factors for progression of brain atrophy in aging - Six-year follow-up of normal subjects
C Enzinger et al.
NEUROLOGY (2005)
Advances in functional and structural MR image analysis and implementation as FSL
SM Smith et al.
NEUROIMAGE (2004)
分享论文
